Prescription Pricing for the People Act of 2023
USA118th CongressS-113| Senate
| Updated: 3/1/2023
Chuck Grassley
Republican Senator
Iowa
Cosponsors (21)
Jeanne Shaheen (Democratic)Tommy Tuberville (Republican)Mike Braun (Republican)Mazie K. Hirono (Democratic)Roger Marshall (Republican)Dianne Feinstein (Democratic)Thomas Tillis (Republican)Christopher A. Coons (Democratic)Marsha Blackburn (Republican)John Boozman (Republican)Robert P. Casey (Democratic)Kyrsten Sinema (Independent)Jacky Rosen (Democratic)James Lankford (Republican)Maria Cantwell (Democratic)Peter Welch (Democratic)Susan M. Collins (Republican)Raphael G. Warnock (Democratic)Richard Blumenthal (Democratic)Ted Budd (Republican)Shelley Moore Capito (Republican)
Judiciary Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Prescription Pricing for the People Act of 20 2 3 This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescription drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on the Judiciary.
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 19.
Commerce
Business ethicsBusiness recordsCompetition and antitrustCongressional oversightConsumer affairsHealth care costs and insuranceHealth information and medical recordsInflation and pricesPrescription drugsRetail and wholesale trades
Prescription Pricing for the People Act of 2023
USA118th CongressS-113| Senate
| Updated: 3/1/2023
Prescription Pricing for the People Act of 20 2 3 This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescription drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on the Judiciary.
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 19.
Chuck Grassley
Republican Senator
Iowa
Cosponsors (21)
Jeanne Shaheen (Democratic)Tommy Tuberville (Republican)Mike Braun (Republican)Mazie K. Hirono (Democratic)Roger Marshall (Republican)Dianne Feinstein (Democratic)Thomas Tillis (Republican)Christopher A. Coons (Democratic)Marsha Blackburn (Republican)John Boozman (Republican)Robert P. Casey (Democratic)Kyrsten Sinema (Independent)Jacky Rosen (Democratic)James Lankford (Republican)Maria Cantwell (Democratic)Peter Welch (Democratic)Susan M. Collins (Republican)Raphael G. Warnock (Democratic)Richard Blumenthal (Democratic)Ted Budd (Republican)Shelley Moore Capito (Republican)
Judiciary Committee
Commerce
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Business ethicsBusiness recordsCompetition and antitrustCongressional oversightConsumer affairsHealth care costs and insuranceHealth information and medical recordsInflation and pricesPrescription drugsRetail and wholesale trades